A Dominantly Acting Murine Allele of Mcm4 Causes Chromosomal Abnormalities and Promotes Tumorigenesis
Authors:
Open Access
- 1 November 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 8 (11) , e1003034
Abstract
Here we report the isolation of a murine model for heritable T cell lymphoblastic leukemia/lymphoma (T-ALL) called Spontaneous dominant leukemia (Sdl). Sdl heterozygous mice develop disease with a short latency and high penetrance, while mice homozygous for the mutation die early during embryonic development. Sdl mice exhibit an increase in the frequency of micronucleated reticulocytes, and T-ALLs from Sdl mice harbor small amplifications and deletions, including activating deletions at the Notch1 locus. Using exome sequencing it was determined that Sdl mice harbor a spontaneously acquired mutation in Mcm4 (Mcm4D573H). MCM4 is part of the heterohexameric complex of MCM2–7 that is important for licensing of DNA origins prior to S phase and also serves as the core of the replicative helicase that unwinds DNA at replication forks. Previous studies in murine models have discovered that genetic reductions of MCM complex levels promote tumor formation by causing genomic instability. However, Sdl mice possess normal levels of Mcms, and there is no evidence for loss-of-heterozygosity at the Mcm4 locus in Sdl leukemias. Studies in Saccharomyces cerevisiae indicate that the Sdl mutation produces a biologically inactive helicase. Together, these data support a model in which chromosomal abnormalities in Sdl mice result from the ability of MCM4D573H to incorporate into MCM complexes and render them inactive. Our studies indicate that dominantly acting alleles of MCMs can be compatible with viability but have dramatic oncogenic consequences by causing chromosomal abnormalities. Our study investigated a spontaneous mouse model for dominantly inherited T-cell leukemia/lymphoma. Using genetic methods, we identified a mutant allele of Mcm4 (Mcm4D573H) in this model. Interestingly, this Mcm4 allele promotes the accumulation of focal chromosomal gains and losses, including aberrations at the Notch1 locus that drive the formation of T-cell leukemia/lymphoma. Previous studies of hypomorphic Mcm alleles have demonstrated that a decrease in MCM levels can cause tumorigenesis. However, total and chromatin bound MCM levels were similar to wild-type in our model, indicating that Mcm alleles that do not drastically impact MCM levels can cause genomic aberrations that drive tumor formation.Keywords
This publication has 45 references indexed in Scilit:
- Mcm2 deficiency results in short deletions allowing high resolution identification of genes contributing to lymphoblastic lymphomaOncogene, 2011
- Mouse genomic variation and its effect on phenotypes and gene regulationNature, 2011
- MCM Proteins Are Negative Regulators of Hypoxia-Inducible Factor 1Molecular Cell, 2011
- Stalled Fork Rescue via Dormant Replication Origins in Unchallenged S Phase Promotes Proper Chromosome Segregation and Tumor SuppressionMolecular Cell, 2011
- DNA damage response and tumorigenesis in Mcm2-deficient miceOncogene, 2010
- Crystal structure of a near-full-length archaeal MCM: Functional insights for an AAA+ hexameric helicaseProceedings of the National Academy of Sciences, 2008
- Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1Journal of Experimental Medicine, 2008
- Evolutionary history and higher order classification of AAA+ ATPasesJournal of Structural Biology, 2004
- Statistical significance for genomewide studiesProceedings of the National Academy of Sciences, 2003
- Comparative Analysis of the Human and Mouse Hey1 Promoter: Hey Genes Are New Notch Target GenesBiochemical and Biophysical Research Communications, 2000